Identification of 2-(2′-fluoro-[1,1′-biphenyl]-2-yl)acetamide as a Sodium Valproate-like broad spectrum anti-epileptic drug candidate
作者:Tomoyuki Tanaka、Nana Yajima、Tomoko Kiyoshi、Yoshiki Miura、Yoshifumi Inoue、Takuya Nishimaki、Seiji Iwama
DOI:10.1016/j.bmcl.2018.12.014
日期:2019.1
By further optimizing compound A [2'-fluoro-N-methyl-[1,1'-biphenyl]-2-sulfonamide], we identified DSP-0565 [2-(2'-fluoro-[1,1'-biphenyl]-2-yl)acetamide, 17a] as a strong, broad-spectrum anti-epileptic drug (AED) candidate. Our efforts mainly focused on finding an alternative polar group for the sulfonamide in order to improve ADME profile of compound A including good metabolic stability and no reactive
通过进一步优化化合物A [2'-氟-N-甲基-[1,1'-联苯] -2-磺酰胺],我们确定了DSP-0565 [2-(2'-氟-[1,1'-联苯] ] -2-基)乙酰胺(17a]是一种强大的广谱抗癫痫药(AED)候选物。我们的努力主要集中在寻找磺酰胺的替代极性基团,以改善化合物A的ADME谱,包括良好的代谢稳定性和无反应性代谢产物。这导致联苯乙酰胺被鉴定为开发广谱AED候选物的新支架。DSP-0565在各种模型(scPTZ,MES,6 Hz和杏仁核点燃)中显示出抗惊厥活性,并具有良好的安全裕度,因此被选为临床候选药物。